Get the Stockscreener App
3.41
1.19%
0.04
After Hours:
3.41
Savara Inc stock is traded at $3.41, with a volume of 1.35M.
It is up +1.19% in the last 24 hours and down -4.21% over the past month.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
See More
Previous Close:
$3.37
Open:
$3.37
24h Volume:
1.35M
Relative Volume:
1.07
Market Cap:
$589.37M
Revenue:
-
Net Income/Loss:
$-54.70M
P/E Ratio:
-10.33
EPS:
-0.33
Net Cash Flow:
$-51.36M
1W Performance:
-1.45%
1M Performance:
-4.21%
6M Performance:
+16.78%
1Y Performance:
-9.55%
1-Day Range:
$3.35
$3.4489
1-Week Range:
$3.34
$3.53
52-Week Range:
$1.89
$4.295
Savara Inc Stock (SVRA) Company Profile
Name
Savara Inc
Sector
Industry
Phone
51285113796
Address
6836 BEE CAVE ROAD, AUSTIN, TX
Compare SVRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SVRA
Savara Inc
|
3.41 | 582.46M | 0 | -54.70M | -51.36M | -0.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Savara Inc Stock (SVRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-15-25 | Upgrade | H.C. Wainwright | Neutral → Buy |
| May-29-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Dec-20-24 | Initiated | Wells Fargo | Overweight |
| Nov-13-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-15-24 | Initiated | JMP Securities | Mkt Outperform |
| Nov-07-23 | Initiated | Guggenheim | Buy |
| May-16-23 | Upgrade | Jefferies | Hold → Buy |
| Mar-31-23 | Downgrade | Jefferies | Buy → Hold |
| Mar-16-21 | Initiated | Piper Sandler | Overweight |
| Mar-15-21 | Initiated | Oppenheimer | Outperform |
| Jun-13-19 | Reiterated | H.C. Wainwright | Buy |
| Jun-13-19 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jun-13-19 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Aug-13-18 | Resumed | ROTH Capital | Neutral |
| Jan-03-18 | Initiated | Ladenburg Thalmann | Buy |
| Sep-27-17 | Resumed | ROTH Capital | Buy |
| Sep-22-17 | Initiated | Jefferies | Buy |
| Sep-11-17 | Initiated | JMP Securities | Mkt Outperform |
View All
Savara Inc Stock (SVRA) Latest News
November 7, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against SVRA - MarketScreener
Securities Fraud Class Action Filed Against Savara Inc. (SVRA)Levi & Korsinsky Reminds Investors of November 7, 2025 - ACCESS Newswire
SVRA INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - GlobeNewswire
SVRA INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - GlobeNewswire Inc.
SAVARA ALERT: Bragar Eagel & Squire, P.C. Urges Investors - GlobeNewswire
SVRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
How to forecast Savara Inc. trends using time series2025 Stock Rankings & Free Verified High Yield Trade Plans - newser.com
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - PR Newswire
Shareholders that lost money on Savara Inc.(SVRA) should contact The Gross Law Firm about pending Class ActionSVRA - Morningstar
Savara: Back On Track With Upcoming APAP BLA Filing (NASDAQ:SVRA) - Seeking Alpha
Weiss Ratings Reaffirms Sell (D-) Rating for Savara (NASDAQ:SVRA) - Defense World
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Savara Inc. - GlobeNewswire
Savara Inc. INVESTOR ALERT: Kirby McInerney LLP Reminds Savara Inc. Investors of Looming Lead ... - Bluefield Daily Telegraph
Savara Inc. INVESTOR ALERT: Kirby McInerney LLP Reminds Savara Inc. Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit | Franklin Credit Management Corporation - FinancialContent
Pomerantz Law Firm Announces the Filing of a Class Action Against Savara Inc. and Certain OfficersSVRA - PR Newswire
SVRA DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - GlobeNewswire
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit - Your Wyoming Link
Savara Inc. (SVRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Lost Money on Savara Inc. (SVRA)? Urged to Join Class Action Before November 7, 2025Contact Levi & Korsinsky - ACCESS Newswire
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Lost Money on Savara Inc. (SVRA)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - GlobeNewswire
Securities Lawsuit Alert: Savara Inc. (SVRA)Contact Levi & Korsinsky Before November 7, 2025 - ACCESS Newswire
Savara Inc. INVESTOR ALERT: Kirby McInerney LLP Reminds - GlobeNewswire
Deadline Alert: Savara Inc. (SVRA) Shareholders Who Lost - GlobeNewswire
SAVARA CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. - GlobeNewswire
SVRA LAWSUIT ALERT: Levi & Korsinsky Notifies Savara Inc. InvestorsLead Plaintiff Deadline November 7, 2025 - ACCESS Newswire
About Us - FinancialContent
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of November 7, 2025 in Savara Inc. LawsuitSVRA - Morningstar
Did You Lose Money on Savara Inc. (SVRA)? Levi & Korsinsky Urges Investors to Act Before November 7, 2025 - ACCESS Newswire
Savara Inc. $SVRA Position Increased by Farther Finance Advisors LLC - Defense World
Levi & Korsinsky Urges Savara Inc. (SVRA) Shareholders to Act Before Lead Plaintiff Deadline November 7, 2025 - ACCESS Newswire
Bragar Eagel & Squire, P.C. Urges Investors of Tronox, - GlobeNewswire
Faruqi & Faruqi Reminds Savara Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2025SVRA - Newsfile
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - MarketScreener
Savara Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationSVRA - FinancialContent
Quantitative breakdown of Savara Inc. recent moveLong Setup & Fast Entry and Exit Trade Plans - newser.com
What indicators show strength in Savara Inc.Insider Buying & Comprehensive Market Scan Insights - newser.com
Savara Announces Encore Presentations of Results From the Phase 3 IMPALA-2 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at CHEST 2025 - BioSpace
Why Savara Inc. stock could benefit from AI revolution2025 Key Lessons & Fast Exit and Entry Trade Guides - newser.com
Savara Inc. stock trend outlook and recovery pathProduct Launch & Real-Time Stock Movement Alerts - newser.com
SVRA NOTICE: Savara Inc. Investors Urged to Contact Kirby McInerney LLP About Securities Fraud Lawsuit - GlobeNewswire
MarketsMedicine Hat News - FinancialContent
Savara to present aPAP diagnosis test data at CHEST 2025 - Investing.com
Savara (SVRA) to Showcase Research at CHEST 2025 Conference - GuruFocus
Savara to present aPAP diagnosis test data at CHEST 2025 By Investing.com - Investing.com Australia
Savara present results from Phase 3 IMPALA-2 Molgramostim study - TipRanks
3 CHEST 2025 Abstracts: Savara Presents Phase 3 IMPALA-2 Molgramostim Data, TrilliumBiO Dried Serum Test - Stock Titan
SVRA Investors Have Opportunity to Lead Savara Inc. Securities F - GuruFocus
Upcoming Virtual Meeting Features SVRA on October 8-9 - GuruFocus
Levi & Korsinsky Notifies Savara Inc. (SVRA) InvestorsLead Plaintiff Deadline on November 7, 2025 - ACCESS Newswire
Investor Alert: Deadline Approaching to Join Savara Inc. (SVRA) Class ActionContact Levi & Korsinsky - ACCESS Newswire
Savara Inc Stock (SVRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Savara Inc Stock (SVRA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| McCracken Joseph S | Director |
May 29 '25 |
Buy |
2.08 |
10,000 |
20,825 |
260,837 |
| RAMSAY DAVID A | Director |
Mar 31 '25 |
Buy |
2.77 |
150,000 |
416,250 |
2,513,642 |
| Lowrance David L | Chief Financial Officer |
Dec 16 '24 |
Sale |
3.33 |
25,000 |
83,278 |
381,005 |
| Pauls Matthew | CHIEF EXECUTIVE OFFICER |
Dec 16 '24 |
Sale |
3.31 |
54,702 |
180,828 |
1,536,379 |
| Hawkins Richard J | Director |
Dec 16 '24 |
Sale |
3.32 |
8,000 |
26,569 |
67,241 |
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):